159 related articles for article (PubMed ID: 33996607)
1. Establishment and Verification of a Predictive Model for Node Pathological Complete Response After Neoadjuvant Chemotherapy for Initial Node Positive Early Breast Cancer.
Zhu J; Jiao D; Yan M; Chen X; Wang C; Lu Z; Li L; Sun X; Qin L; Guo X; Zhang C; Qiao J; Li J; Fan Z; Wang H; Zhang J; Yin Y; Fu P; Geng C; Jin F; Jiang Z; Cui S; Liu Z
Front Oncol; 2021; 11():675070. PubMed ID: 33996607
[TBL] [Abstract][Full Text] [Related]
2. Prediction of axillary response after neoadjuvant chemotherapy in clinical node positive breast cancer.
Zheng W; Zhou P; Liu Y; Liang Y; Wang Y
Transl Cancer Res; 2021 Jun; 10(6):2822-2830. PubMed ID: 35116592
[TBL] [Abstract][Full Text] [Related]
3. [Construction of a nomogram prediction model for pathological complete response (pCR) of ipsilateral supraclavicular lymph node after neoadjuvant chemotherapy for breast cancer with first diagnosis of ipsilateral supraclavicular lymph node metastasis].
Lyu MH; Jiao DC; Wu JZ; Tian PQ; Ma YZ; Liu ZZ; Chen XC
Zhonghua Zhong Liu Za Zhi; 2022 Feb; 44(2):160-166. PubMed ID: 35184460
[No Abstract] [Full Text] [Related]
4. Association of higher axillary pathologic complete response rate with breast pathologic complete response after neoadjuvant chemotherapy.
Zhu J; Li J; Fan Z; Wang H; Zhang J; Yin Y; Fu P; Geng C; Jin F; Jiang Z; Liu Z
Ann Transl Med; 2020 Aug; 8(16):992. PubMed ID: 32953792
[TBL] [Abstract][Full Text] [Related]
5. The predicted probability of having positive non-sentinel lymph nodes in patients who received neoadjuvant chemotherapy for large operable breast cancer.
Evrensel T; Johnson R; Ahrendt G; Bonaventura M; Falk JS; Keenan D; Soran A
Int J Clin Pract; 2008 Sep; 62(9):1379-82. PubMed ID: 17309608
[TBL] [Abstract][Full Text] [Related]
6. Preoperative Prediction of Node-Negative Disease After Neoadjuvant Chemotherapy in Patients Presenting with Node-Negative or Node-Positive Breast Cancer.
Murphy BL; L Hoskin T; Heins CDN; Habermann EB; Boughey JC
Ann Surg Oncol; 2017 Sep; 24(9):2518-2525. PubMed ID: 28484921
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of Charcoal Tattooing of Cytology-Proven Metastatic Axillary Lymph Node at Diagnosis and Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients.
Park S; Koo JS; Kim GM; Sohn J; Kim SI; Cho YU; Park BW; Park VY; Yoon JH; Moon HJ; Kim MJ; Kim EK
Cancer Res Treat; 2018 Jul; 50(3):801-812. PubMed ID: 28814071
[TBL] [Abstract][Full Text] [Related]
8. A Nomogram for Predicting the Pathological Response of Axillary Lymph Node Metastasis in Breast Cancer Patients.
Jin X; Jiang YZ; Chen S; Shao ZM; Di GH
Sci Rep; 2016 Aug; 6():32585. PubMed ID: 27576704
[TBL] [Abstract][Full Text] [Related]
9. Update on sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer patient.
Franceschini G; Di Leone A; Sanchez AM; D'Archi S; Terribile D; Magno S; Scardina L; Masetti R
Ann Ital Chir; 2020; 91():465-468. PubMed ID: 32312945
[TBL] [Abstract][Full Text] [Related]
10. Can nomograms predict non-sentinel lymph node metastasis after neoadjuvant chemotherapy in sentinel lymph node-positive breast cancer patients?
Unal B; Gur AS; Ahrendt G; Johnson R; Bonaventura M; Soran A
Clin Breast Cancer; 2009 May; 9(2):92-5. PubMed ID: 19433389
[TBL] [Abstract][Full Text] [Related]
11. Development of a predictive model utilizing the neutrophil to lymphocyte ratio to predict neoadjuvant chemotherapy efficacy in early breast cancer patients.
Zhu J; Jiao D; Zhao Y; Guo X; Yang Y; Xiao H; Liu Z
Sci Rep; 2021 Jan; 11(1):1350. PubMed ID: 33446717
[TBL] [Abstract][Full Text] [Related]
12. A Novel Less-invasive Approach for Axillary Staging After Neoadjuvant Chemotherapy in Patients With Axillary Node-positive Breast Cancer by Combining Radioactive Iodine Seed Localization in the Axilla With the Sentinel Node Procedure (RISAS): A Dutch Prospective Multicenter Validation Study.
van Nijnatten TJA; Simons JM; Smidt ML; van der Pol CC; van Diest PJ; Jager A; van Klaveren D; Kam BLR; Lobbes MBI; de Boer M; Verhoef K; Koppert LB; Luiten EJT
Clin Breast Cancer; 2017 Aug; 17(5):399-402. PubMed ID: 28487053
[TBL] [Abstract][Full Text] [Related]
13. A model to predict pathologic complete response of axillary lymph nodes to neoadjuvant chemo(immuno)therapy in patients with clinically node-positive breast cancer.
Schipper RJ; Moossdorff M; Nelemans PJ; Nieuwenhuijzen GA; de Vries B; Strobbe LJ; Roumen RM; van den Berkmortel F; Tjan-Heijnen VC; Beets-Tan RG; Lobbes MB; Smidt ML
Clin Breast Cancer; 2014 Oct; 14(5):315-22. PubMed ID: 24548732
[TBL] [Abstract][Full Text] [Related]
14. Feasibility and validation of the targeted axillary dissection technique in the axillary staging of breast cancer after neoadjuvant therapy: Definitive results.
Flores-Funes D; Aguilar-Jiménez J; Martínez-Gálvez M; Ibáñez-Ibáñez MJ; Carrasco-González L; Gil-Izquierdo JI; Chaves-Benito MA; Ayala-De La Peña F; Nieto-Olivares A; Aguayo-Albasini JL
Surg Oncol; 2021 Sep; 38():101636. PubMed ID: 34303211
[TBL] [Abstract][Full Text] [Related]
15. Nomogram for predicting axillary lymph node pathological response in node-positive breast cancer patients after neoadjuvant chemotherapy.
Wang W; Wang X; Liu J; Zhu Q; Wang X; Wang P
Chin Med J (Engl); 2021 Dec; 135(3):333-340. PubMed ID: 35108228
[TBL] [Abstract][Full Text] [Related]
16. Sentinel Lymph Node Biopsy in Breast Cancer Patients With Pathological Complete Response in the Axillary Lymph Node After Neoadjuvant Chemotherapy.
Kim H; Han J; Kim SY; Lee ES; Kang HS; Lee S; Jung SY; Lee E
J Breast Cancer; 2021 Dec; 24(6):531-541. PubMed ID: 34979599
[TBL] [Abstract][Full Text] [Related]
17. Establishment of a model for predicting sentinel lymph node metastasis in early breast cancer based on contrast-enhanced ultrasound and clinicopathological features.
Wang L; Li J; Qiao J; Guo X; Bian X; Guo L; Liu Z; Lu Z
Gland Surg; 2021 May; 10(5):1701-1712. PubMed ID: 34164314
[TBL] [Abstract][Full Text] [Related]
18. Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with cytologically proven node-positive breast cancer at diagnosis.
Park S; Park JM; Cho JH; Park HS; Kim SI; Park BW
Ann Surg Oncol; 2013 Sep; 20(9):2858-65. PubMed ID: 23645483
[TBL] [Abstract][Full Text] [Related]
19. A nomogram for predicting axillary pathologic complete response in hormone receptor-positive breast cancer with cytologically proven axillary lymph node metastases.
Guo R; Su Y; Si J; Xue J; Yang B; Zhang Q; Chi W; Chen J; Chi Y; Shao Z; Wu J
Cancer; 2020 Aug; 126 Suppl 16():3819-3829. PubMed ID: 32710664
[TBL] [Abstract][Full Text] [Related]
20. Selective sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer: results of the GEICAM 2005-07 study.
Piñero-Madrona A; Escudero-Barea MJ; Fernández-Robayna F; Alberro-Adúriz JA; García-Fernández A; Vicente-García F; Dueñas-Rodriguez B; Lorenzo-Campos M; Caparrós X; Cansado-Martínez MP; Ramos-Boyero M; Rojo-Blanco R; Serra-Genís C
Cir Esp; 2015 Jan; 93(1):23-9. PubMed ID: 24560631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]